Silexion Therapeutics (SLXN) Shares Outstanding (2023 - 2026)

Silexion Therapeutics' Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $339486.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 651.13% year-over-year to $339486.0; the TTM figure through Mar 2026 stood at $339486.0 (up 651.13% YoY), while the FY2025 annual figure was $132952.0, up 3096.73% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $339486.0, up from $132952.0 in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $339486.0 in Q1 2026, with the low at $186.0 in Q2 2024.
• The 4-year median for Shares Outstanding (Entity) is $4238.0 (2024), against an average of $58320.1.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) fell 0.53% in 2024, then surged 31058.06% in 2025.
• Silexion Therapeutics' Shares Outstanding (Entity) stood at $745.0 in 2023, then surged by 458.26% to $4159.0 in 2024, then soared by 3096.73% to $132952.0 in 2025, then soared by 155.34% to $339486.0 in 2026.
• Business Quant data shows SLXN's Shares Outstanding (Entity) at $339486.0 in Q1 2026, $132952.0 in Q4 2025, and $113266.0 in Q3 2025.